5 evolution "https:" "https:" "https:" "CMU Portugal Program FCT" positions at FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA in Spain
-
on: i) the development and characterization of innovative CAR-T therapies in advanced preclinical models; ii) the implementation of CAR-T therapies for clinical use; iii) the characterization
-
recent years because the therapies used are not effective in eradicating these aberrant cells. Therefore, the identification of the molecular mechanisms involved in the development and progression of MDS
-
and progression of MDS will allow the identification of targets for the development of new therapies that can eliminate aberrant cells and prevent or slow disease progression. Last publications: https
-
, as well as with genetically modified mouse and pig models. Last publications: https://pubmed.ncbi.nlm.nih.gov/40551151/ https://pubmed.ncbi.nlm.nih.gov/37967560/ https://pubmed.ncbi.nlm.nih.gov
-
heart in health and disease. Last publications: https://pubmed.ncbi.nlm.nih.gov/40227978/ https://pubmed.ncbi.nlm.nih.gov/40619379/ https://pubmed.ncbi.nlm.nih.gov/39456491/ https